With increasing demand for cell and gene therapies, mesenchymal stem cells (MSCs) have gained attention for their versatility ...

The healthcare industry has shared its concerns on a global scale after President Trump signed the executive order.

This rising trend mirrors the evolution of the pharmaceutical industry in terms of investment and utilisation of novel ...

Health Canada has granted market authorisation to Takeda Canada for FRUZAQLA capsules to treat adults with mCRC.

Investment company RTW Investments has launched a new biotech company called Prolium Bioscience, to advance the development ...

This week, at the J.P. Morgan Healthcare Conference and the Biotech Showcase, discussions underscored the growing focus on ...

Moderna is set to receive $590m in funding from the HHS to expedite the development of mRNA-based pandemic influenza vaccines ...

If the results from the clinical development plans are positive, it may well reflect a paradigm shift for clinical care.

The EC has approved GSK's Jemperli (dostarlimab) combined with chemotherapy for primary advanced or recurrent endometrial cancer in adults.